SEC Form 3 · accession 0001015820-16-000092
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
QIAGEN NV
10% Owner
Period of report
Nov 17, 2016
Accepted (ET)
Nov 22, 2016 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 833,333 | I | Held through QIAGEN North America Holdings, Inc. a wholly owned subsidiary |
Table II — derivative securities
No Table II lines on this filing.
Remarks
(1) The Common Stock of the Issuer are held of record by QIAGEN North American Holdings, Inc., a wholly owned subsidiary of QIAGEN N.V. (2) This report on Form 3 is filed jointly by QIAGEN N.V. and QIAGEN North American Holdings, Inc.